296 results on '"Teh, Bin T."'
Search Results
2. Multiple Endocrine Neoplasia Type 1
3. Molecular Genetics of Renal Cell Carcinoma
4. Gene profiling suggests a common evolution of bladder cancer subtypes
5. Osteoblast-specific deletion of Hrpt2/Cdc73 results in high bone mass and increased bone turnover
6. Supplementary Table 1 from Next-Generation Sequencing of Translocation Renal Cell Carcinoma Reveals Novel RNA Splicing Partners and Frequent Mutations of Chromatin-Remodeling Genes
7. Supplementary Methods from Next-Generation Sequencing of Translocation Renal Cell Carcinoma Reveals Novel RNA Splicing Partners and Frequent Mutations of Chromatin-Remodeling Genes
8. Supplementary Figure S1 from The Investigational Aurora Kinase A Inhibitor MLN8237 Induces Defects in Cell Viability and Cell-Cycle Progression in Malignant Bladder Cancer Cells In Vitro and In Vivo
9. Supplementary Table 3 from Next-Generation Sequencing of Translocation Renal Cell Carcinoma Reveals Novel RNA Splicing Partners and Frequent Mutations of Chromatin-Remodeling Genes
10. Supplementary Table 2 from Next-Generation Sequencing of Translocation Renal Cell Carcinoma Reveals Novel RNA Splicing Partners and Frequent Mutations of Chromatin-Remodeling Genes
11. Supplementary Data from Prognostic Value of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (TRAIL) and TRAIL Receptors in Renal Cell Cancer
12. Supplementary Table 4 from Next-Generation Sequencing of Translocation Renal Cell Carcinoma Reveals Novel RNA Splicing Partners and Frequent Mutations of Chromatin-Remodeling Genes
13. Supplementary Table 5 from Next-Generation Sequencing of Translocation Renal Cell Carcinoma Reveals Novel RNA Splicing Partners and Frequent Mutations of Chromatin-Remodeling Genes
14. Supplementary Figure Legends from The Investigational Aurora Kinase A Inhibitor MLN8237 Induces Defects in Cell Viability and Cell-Cycle Progression in Malignant Bladder Cancer Cells In Vitro and In Vivo
15. Supplementary Table 6 from Next-Generation Sequencing of Translocation Renal Cell Carcinoma Reveals Novel RNA Splicing Partners and Frequent Mutations of Chromatin-Remodeling Genes
16. Supplementary Figure 1 from Next-Generation Sequencing of Translocation Renal Cell Carcinoma Reveals Novel RNA Splicing Partners and Frequent Mutations of Chromatin-Remodeling Genes
17. Supplementary Table Legends 1-5, Figures 1-8 from Combined Gene Expression Profiling and RNAi Screening in Clear Cell Renal Cell Carcinoma Identify PLK1 and Other Therapeutic Kinase Targets
18. Data from Robust Classification of Renal Cell Carcinoma Based on Gene Expression Data and Predicted Cytogenetic Profiles
19. Supplementary Figure 1 from Robust Classification of Renal Cell Carcinoma Based on Gene Expression Data and Predicted Cytogenetic Profiles
20. Supplementary Table 4 from Combined Gene Expression Profiling and RNAi Screening in Clear Cell Renal Cell Carcinoma Identify PLK1 and Other Therapeutic Kinase Targets
21. Data from Combined Gene Expression Profiling and RNAi Screening in Clear Cell Renal Cell Carcinoma Identify PLK1 and Other Therapeutic Kinase Targets
22. Supplementary Table 1 from Robust Classification of Renal Cell Carcinoma Based on Gene Expression Data and Predicted Cytogenetic Profiles
23. 6 Supplementary Tables from Gene Expression of Parathyroid Tumors
24. 'Seed and Soil' Theory of Metastasis
25. An Integrated Oncogenomic Approach: From Genes to Pathway Analyses
26. Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia
27. Multiple Endocrine Neoplasia Type 1
28. Clear cell sarcomas of the kidney are characterised by BCOR gene abnormalities, including exon 15 internal tandem duplications and BCOR–CCNB3 gene fusion
29. Glypican 3 overexpression in primary and metastatic Wilms tumors
30. Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomas
31. Downregulation of CASR expression and global loss of parafibromin staining are strong negative determinants of prognosis in parathyroid carcinoma
32. “Seed and Soil” Theory of Metastasis
33. Multiple Endocrine Neoplasia Type 1
34. Maximizing RNA Yield from Archival Renal Tumors and Optimizing Gene Expression Analysis
35. Kinase targets in renal-cell carcinomas: reassessing the old and discovering the new
36. A germline mutation in PBRM1 predisposes to renal cell carcinoma
37. Whole-Exome Sequencing Studies of Parathyroid Carcinomas Reveal Novel PRUNE2 Mutations, Distinctive Mutational Spectra Related to APOBEC-Catalyzed DNA Mutagenesis and Mutational Enrichment in Kinases Associated With Cell Migration and Invasion
38. A comparison study reveals important features of agreement and disagreement between summarized DNA and RNA data obtained from renal cell carcinoma
39. Signatures of mutation and selection in the cancer genome
40. Molecular targets on the horizon for kidney and urothelial cancer
41. Folliculin interacts with p0071 (plakophilin-4) and deficiency is associated with disordered RhoA signalling, epithelial polarization and cytokinesis
42. An Integrated Oncogenomic Approach: From Genes to Pathway Analyses
43. Whole exome sequencing identifies clinically relevant mutational signatures in resected hepatocellular carcinoma
44. Prospective Clinical Trial of Preoperative Sunitinib in Patients With Renal Cell Carcinoma
45. The tumor suppressor parafibromin is required for posttranscriptional processing of histone mRNA
46. Expression and chromosomal localization of the Requiem gene
47. Accuracy of Combined Protein Gene Product 9.5 and Parafibromin Markers for Immunohistochemical Diagnosis of Parathyroid Carcinoma
48. Gene expression profiling of renal cell carcinoma and clinical implications
49. Fine mapping of the MLK-3 gene within 11q13 and its exclusion as the MEN1 susceptibility gene
50. Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.